ADMA Biologics, Inc. (ADMA) scores 51 out of 100 on boothcheck's 11-model valuation framework. Verdict: Avoid The estimated fair value is $15.74, representing a 16% margin of safety. Quantitative score: 56/100. Qualitative score: 60/100.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.